Real-time Price Updates for Fsd Pharma Inc Subordinate Voting Share (HUGE-CN), along with buy or sell indicators, analysis, charts, historical performance, news and more FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD, an ultra-micronized palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular (NASDAQ: HUGE) Fsd Pharma currently has 39,, outstanding shares. With Fsd Pharma stock trading at $ per share, the total value of Fsd Pharma stock FSD Pharma Inc., a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and View FSD Pharma Inc. Class B HUGE stock quote prices, financial information, real-time forecasts, and company news from CNN FSD Pharma Inc., is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions. In May , GBB filed a lawsuit against FSD Pharma alleging a FSD Pharma (NASDAQ: HUGE) (FRA:0K9A) announced that through HUGE Biopharma Australia, it entered into an agreement with Ingenu CRO to assess the safety and efficacy of unbuzzd in healthy MarketWatch. IBD. FSD Pharma Inc. HUGE (U.S.: Nasdaq) Overview. News FSD Pharma Inc. Significant News Only. No significant news for HUGE in the past two years. Key
Safety Shot Responds to FSD Pharma’s 3rd unauthorized Tagging …
The share float percentage for the stock currently stands at %. There are % institutions holding the FSD Pharma Inc stock share, with AdvisorShares Investments, LLC the top institutional holder. As of Jun 29, , the company held % of the shares, roughly million HUGE shares worth $ million FSD Pharma Inc. Class B Subordinate Voting Shares (HUGE) Real-Time Quotes | Nasdaq. Real-Time: HUGE. Edit my quotes. FSD Pharma Inc. Class B Subordinate Voting TORONTO, ON / ACCESSWIRE / October 23, / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of FSD Pharma Inc., a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders HUGE: FSD Pharma Inc Stock Price Quote - NASDAQ CM - Bloomberg. S&P 5, +% Nasdaq. 16, +% Crude Oil. +%
FSD Pharma Inc. Stock Quote (U.S.: Nasdaq) - MarketWatch
1 day ago · TORONTO, ON / ACCESSWIRE / February 16, / FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FRA:0K9A) ("FSD Pharma" or the "Company"), a The “FSD Pharma issues corporate updates” public release (April 7, ) New MorningStar report issued highlighting FSD Pharma (NASDAQ: HUGE) (TSX: HUGE) FSD Pharma ready to proceed with Phase 2 clinical trial of FSD as soon as it gets clearance. FSD Pharma announced the submission of an Investigational New Drug or “IND” FSD Pharma BioSciences, Inc., a wholly-owned subsidiary, is a specialty biotech pharmaceutical R&D company focused on developing over time multiple applications of its lead compound FSD, by TORONTO, ON / ACCESSWIRE / February 28, / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that its board of directors has approved the Toronto, Ontario -- January 13, FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, is pleased to announce that its Board of Directors has authorized the